Skip to main content

Medtronic plc

MDT
Exchange
NYSE
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001613103

In the last 90 days, Medtronic plc insiders filed 0 open-market purchases and 2 sales; 2,149 institutions reported holding it in 13F filings for Q2 2026, worth $86.8B in total; no superinvestor holds it.

Holders of 5% or more of MDT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Medtronic plc, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of MDT
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A6.90%88.7M shares–Apr 23, 20251 filingApr 23, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

3 Schedule 13D and 13G filings on Medtronic plc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on MDT
Filed (ET)FilerFormStakeChangeEvent dateFiling
Mar 27, 202610:30 AM ETVanguard Group Inc13G/A0.00%0 shares−10.21 ppfrom 10.21%Below 5%Mar 13, 2026SEC
Dec 3, 202511:20 AM ETVanguard Group Inc13G/A10.21%130.9M shares–Nov 28, 2025SEC
Apr 23, 20258:00 PM ETBlackRock, Inc.13G/A6.90%88.7M shares–Mar 31, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Medtronic plc shares.

No Form 144 notices for Medtronic plc are on file.